Recent additions may not be included but will usually appear in 24 hrs or less.
Rational | Source |
---|---|
[Research cited on Manufacture Website]. β
Research cited on Manufacture Website (WebSite ) Vol: 0 Issue 0 Pages: 0 Pub: 2018 Jan Epub: Authors Miyarisan Labs , |
|
[Research cited on Manufacture Website]. β
Research cited on Manufacture Website (WebSite ) Vol: 0 Issue 0 Pages: 0 Pub: 2018 Jan Epub: Authors Miyarisan Labs , |
|
[Research cited on Manufacture Website]. β
Research cited on Manufacture Website (WebSite ) Vol: 0 Issue 0 Pages: 0 Pub: 2018 Jan Epub: Authors Miyarisan Labs , |
|
[Research cited on Manufacture Website]. β
Research cited on Manufacture Website (WebSite ) Vol: 0 Issue 0 Pages: 0 Pub: 2018 Jan Epub: Authors Miyarisan Labs , |
|
<i>Clostridium butyricum</i> CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1345 Pub: 2017 Epub: 2017 Oct 19 Authors Jia L , Shan K , Pan LL , Feng N , Lv Z , Sun Y , Li J , Wu C , Zhang H , Chen W , Diana J , Sun J , Chen YQ , |
|
Oral administration of Clostridium butyricum for modulating gastrointestinal microflora in mice. β
Go to Publication β
Current microbiology (Curr Microbiol ) Vol: 62 Issue 2 Pages: 512-7 Pub: 2011 Feb Epub: 2010 Aug 15 Authors Kong Q , He GQ , Jia JL , Zhu QL , Ruan H , |
|
Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis. β
Go to Publication β
iScience (iScience ) Vol: 23 Issue 1 Pages: 100772 Pub: 2020 Jan 24 Epub: 2019 Dec 13 Authors Hagihara M , Kuroki Y , Ariyoshi T , Higashi S , Fukuda K , Yamashita R , Matsumoto A , Mori T , Mimura K , Yamaguchi N , Okada S , Nonogaki T , Ogawa T , Iwasaki K , Tomono S , Asai N , Koizumi Y , Oka K , Yamagishi Y , Takahashi M , Mikamo H , |
|
Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host. β
Go to Publication β
Biomedicines (Biomedicines ) Vol: 9 Issue 8 Pages: Pub: 2021 Aug 22 Epub: 2021 Aug 22 Authors Ariyoshi T , Hagihara M , Tomono S , Eguchi S , Minemura A , Miura D , Oka K , Takahashi M , Yamagishi Y , Mikamo H , |
|
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 816891 Pub: 2022 Epub: 2022 May 20 Authors Xu T , Yang D , Liu K , Gao Q , Liu Z , Li G , |
|
Clostridium butyricum and Clostridium tyrobutyricum: angel or devil for necrotizing enterocolitis? β
Go to Publication β
mSystems (mSystems ) Vol: Issue Pages: e0073223 Pub: 2023 Nov 3 Epub: 2023 Nov 3 Authors Tao R , Zong G , Pan Y , Li H , Cheng P , Deng R , Chen W , Wang A , Xia S , Tang W , Lu Y , Wei Z , |
|
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332 Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R , |
|
Uncovering the mechanism of Clostridium butyricum CBX 2021 to improve pig health based on in vivo and in vitro studies. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1394332 Pub: 2024 Epub: 2024 Jun 14 Authors Liu X , Qiu X , Yang Y , Wang J , Wang Q , Liu J , Huang J , Yang F , Liu Z , Qi R , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]